Literature DB >> 19545540

Paradoxical effect of L-arginine: acceleration of endothelial cell senescence.

Fortunato Scalera1, Ellen I Closs, Eva Flick, Jens Martens-Lobenhoffer, Jean P Boissel, Uwe Lendeckel, Anke Heimburg, Stefanie M Bode-Böger.   

Abstract

We have recently shown that inhibition of nitric oxide (NO) synthesis by asymmetrical dimethylarginine (ADMA) accelerated endothelial cell (EC) senescence which was prevented by coincubation with L-arginine; however the effect of long-term treatment of l-arginine alone on senescence of ECs have not been investigated. Human ECs were cultured in medium containing different concentrations of L-arginine until senescence. L-Arginine paradoxically accelerated senescence indicated by inhibiting telomerase activity. Moreover, L-arginine decreased NO metabolites, increased peroxynitrite, and 8-iso-prostaglandin F(2alpha) formation. In old cells, the mRNA expression of human amino acid transporter (hCAT)2B, the activity and protein expression of arginase II were upregulated indicated by enhanced urea, L-ornithine, and L-arginine consumption. Inhibition of arginase activity, or transfection with arginase II siRNA prevented L-arginine-accelerated senescence. The most possible explanation for the paradoxical acceleration of senescence by L-arginine so far may be the translational and posttranslational activation of arginase II.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545540     DOI: 10.1016/j.bbrc.2009.06.091

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Arginase: an old enzyme with new tricks.

Authors:  Ruth B Caldwell; Haroldo A Toque; S Priya Narayanan; R William Caldwell
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

2.  Hypoxic upregulation of arginase II in human lung endothelial cells.

Authors:  Karina Krotova; Jawaharlal M Patel; Edward R Block; Sergey Zharikov
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-22       Impact factor: 4.249

Review 3.  The Arginase Pathway in Neonatal Brain Hypoxia-Ischemia.

Authors:  Jana Krystofova; Praneeti Pathipati; Jeffrey Russ; Ann Sheldon; Donna Ferriero
Journal:  Dev Neurosci       Date:  2019-04-17       Impact factor: 2.984

4.  Asymmetric dimethylarginine predicts survival in the elderly.

Authors:  Francesco Pizzarelli; Renke Maas; Pietro Dattolo; Giovanni Tripepi; Stefano Michelassi; Graziella D'Arrigo; Maren Mieth; Stefania Bandinelli; Luigi Ferrucci; Carmine Zoccali
Journal:  Age (Dordr)       Date:  2013-04-13

Review 5.  Arginase: A Multifaceted Enzyme Important in Health and Disease.

Authors:  R William Caldwell; Paulo C Rodriguez; Haroldo A Toque; S Priya Narayanan; Ruth B Caldwell
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 6.  Healthy aging and disease: role for telomere biology?

Authors:  Haidong Zhu; Matthew Belcher; Pim van der Harst
Journal:  Clin Sci (Lond)       Date:  2011-05       Impact factor: 6.124

7.  Long term exposure to L-arginine accelerates endothelial cell senescence through arginase-II and S6K1 signaling.

Authors:  Yuyan Xiong; Michael Forbiteh Fru; Yi Yu; Jean-Pierre Montani; Xiu-Fen Ming; Zhihong Yang
Journal:  Aging (Albany NY)       Date:  2014-05       Impact factor: 5.682

Review 8.  Functions of arginase isoforms in macrophage inflammatory responses: impact on cardiovascular diseases and metabolic disorders.

Authors:  Zhihong Yang; Xiu-Fen Ming
Journal:  Front Immunol       Date:  2014-10-27       Impact factor: 7.561

9.  Role of p38 mitogen-activated protein kinase in vascular endothelial aging: interaction with Arginase-II and S6K1 signaling pathway.

Authors:  Zongsong Wu; Yi Yu; Chang Liu; Yuyan Xiong; Jean-Pierre Montani; Zhihong Yang; Xiu-Fen Ming
Journal:  Aging (Albany NY)       Date:  2015-01       Impact factor: 5.682

10.  Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation.

Authors:  Zhihong Yang; Xiu-Fen Ming
Journal:  Front Immunol       Date:  2013-06-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.